Symptom burden, coagulopathy and heart disease after acute SARS-CoV-2 infection in primary practice.

SETANTA (Study of HEarT DiseAse and ImmuNiTy After COVID-19 in Ireland) study aimed to investigate symptom burden and incidence of cardiac abnormalities after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)/COVID-19 and to correlate these results with biomarkers of immunological response and coagulation. SETANTA was a prospective, single-arm observational cross-sectional study condcuted in a primary practice setting, and prospectively registered with ClinicalTrials.gov (identifier: NCT04823182).

MRI safety management in patients with cardiac implantable electronic devices: Utilizing failure mode and effects analysis for risk optimization.

Introduction: Cardiac implantable electronic devices (CIEDs) are increasing in prevalence. Exposing patients with CIEDs to magnetic resonance imaging (MRI) can lead to adverse outcomes. This has led certain radiology departments to not accept MRI referrals related to patients with CIEDs.

Provision of MR imaging for patients with cardiac implantable electronic devices (CIEDs): a single-center experience and national survey.

Background: Patients with cardiac implantable electronic devices (CIEDs) were traditionally denied access to MR imaging due to safety concerns.

Aims: The aim of this study was to review a single-center experience of MR imaging at 1.5T of patients with CIEDs and survey national availability of this service.

Impact of sensory design interventions on image quality, patient anxiety and overall patient experience at MRI.

Objective: This study aimed to assess the effect of sensory stimulation on patient MRI experience and to assess whether sensory stimulation has a significant effect on MR image quality.

Methods: A case-control study was conducted over 4 months, involving patients undergoing MRI brain, cervical spine, breast and prostate. The study involved 106 patients, 64 cases and 42 controls.